Key result
Initial bedside testing matches initial V/Q scanning for recurrent venous thromboembolism risk.
Why the study?
It was uncertain whether using combinations of 3 bedside tests to exclude pulmonary embolism before diagnostic imaging was as safe as starting with ventilation-perfusion scan.
Does a combination of 3 bedside tests safely exclude pulmonary embolism and reduce the need for diagnostic imaging compared to initial V/Q scan in adults with suspected pulmonary embolism?
RCT (n=399)
Double-blind
randomized
Does a combination of 3 bedside tests safely exclude pulmonary embolism and reduce the need for diagnostic imaging compared to initial V/Q scan in adults with suspected pulmonary embolism?
Using a combination of 3 bedside tests safely excludes pulmonary embolism and eliminates the need for diagnostic imaging in 34% of patients with suspected PE.
Answers are grounded in this paper and cite their sources.
Bedside combination safely excludes PE in 34% without imaging; confirms equivalency to initial V/Q scanning.
BACKGROUND: We sought to determine whether using combinations of 3 bedside tests (7-variable clinical model, non-enzyme-linked immunosorbent assay D-dimer test, and alveolar dead-space fraction) to exclude pulmonary embolism (PE) before diagnostic imaging was as safe as a standard strategy of starting with ventilation-perfusion (V/Q) scan. METHODS: In this double-blind, randomized, controlled equivalency trial, patients were randomized to initial bedside tests or to initial V/Q scan without bedside tests. Patients assigned to the bedside test group had a sham V/Q scan performed if at least 2 of 3 bedside test results were negative; otherwise, they underwent an actual V/Q scan. Further diagnostic management was determined by a blinded physician after V/Q scan. The primary outcome measure was recurrent venous thromboembolic events during 3 months among patients who were not taking anticoagulant agents after the initial investigations were completed. RESULTS: Four hundred fifty-eight consecutive adults with suspected PE were eligible for the study; 398 of 399 consenting and randomized patients completed the study. The follow-up venous thromboembolic event rate was 2.4% in the bedside test group vs 3.0% in the V/Q scan group (P = .76). Pulmonary embolism was excluded in 34% (67/199) of the bedside test group patients with at least 2 negative results on 3 bedside tests vs 18% (35/199) excluded using only the 7-variable clinical model and the D-dimer test. CONCLUSION: Excluding PE with at least 2 negative results on 3 bedside tests safely eliminates the need for diagnostic imaging in 34% of patients with suspected PE.
No takes yet. Share an insight, caveat, or question.
Rodger et al. (2006) conducted an RCT in suspected pulmonary embolism (n=399). Initial bedside tests (7-variable clinical model, non-ELISA D-dimer test, and alveolar dead-space fraction) vs. Initial ventilation-perfusion (V/Q) scan was evaluated on recurrent venous thromboembolic events during 3 months among patients who were not taking anticoagulant agents after the initial investigations were completed (p=0.76). Using 3 bedside tests to exclude pulmonary embolism was equivalent to starting with a V/Q scan, with recurrent venous thromboembolic event rates of at 3 months.
Synapse has enriched 10 related papers. Consider them for comparative context: